Target intelligence / Profile preview

Host cell glycoprotein and glycolipid

Molecular classification
Other
01

Overview

**Host cell glycoproteins and glycolipids** are classes of molecules present on the surface of virtually all eukaryotic cells. Glycoproteins are proteins to which one or more carbohydrate groups are covalently attached, while glycolipids are lipids with covalently attached carbohydrate groups[1][3][5]. Both are major components of the cell membrane and form part of the glycocalyx—a carbohydrate-rich coating that surrounds cells. They are involved in crucial biological functions including cell-cell recognition, cell adhesion, structural integrity, and signal transduction. Glycoproteins and glycolipids serve as receptors or ligands in cell signaling and mediate key processes in immune response and pathogen infection, such as acting as recognition sites for viral or bacterial attachment[2][3][6]. The term itself is **not specific to a single molecular entity or target**; rather, it refers to broad classes with diverse structure and function[1][3]. Many pathogens exploit these molecules to gain cell entry, and changes in glycosylation patterns are implicated in diseases like cancer, inflammation, and infection. However, due to their structural heterogeneity and widespread expression, generic "host glycoproteins and glycolipids" are not considered specific, well-defined drug targets[1][3][6][5].\n\n**Note:**\n- This entry is inappropriate as a specific drug target because it refers to an entire heterogeneous class rather than a unique molecule, receptor, or protein family. Please clarify if you are referring to a particular glycoprotein or glycolipid (such as "ACE2," "CD4," or "GM1 ganglioside").

Other names
Cell surface glycoproteinCell surface glycolipidMembrane glycoproteinMembrane glycolipid
02

Biological functions

Cell-cell recognitionCell adhesionSignal transductionImmune responseStructural integrity
03

Disease associations

InfectionCancerInflammationImmune-related disease
04

Safety considerations

Complexity and heterogeneity of structures complicate drug targetingUbiquitous expression can lead to off-target effects

Beyond the preview

Go deeper on Host cell glycoprotein and glycolipid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host cell glycoprotein and glycolipid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call